Alliancebernstein L.P. Mirum Pharmaceuticals, Inc. Transaction History

Alliancebernstein L.P.

$287 Billion
Q3 2024

A detailed history of Alliancebernstein L.P. transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 41,050 shares of MIRM stock, worth $2.06 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

41,050

Previous 41,050 -0.0%

Holding current value

$2.06 Million

Previous $1.4 Million 14.04%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$23.57 - $34.85 $399,511 - $590,707	16,950 Added 70.33%	41,050 $1.4 Million
Q1 2024 May 14, 2024	SELL	$24.92 - $30.02 $201,901 - $243,222	-8,102 Reduced 25.16%	24,100 $605,000
Q4 2023 Feb 14, 2024	SELL	$27.14 - $34.93 $180,046 - $231,725	-6,634 Reduced 17.08%	32,202 $950,000
Q3 2023 Nov 14, 2023	BUY	$24.63 - $32.85 $74,727 - $99,666	3,034 Added 8.47%	38,836 $1.23 Million
Q2 2023 Aug 15, 2023	BUY	$23.51 - $30.09 $275,114 - $352,113	11,702 Added 48.56%	35,802 $926,000
Q4 2022 Feb 14, 2023	BUY	$17.59 - $23.83 $61,565 - $83,405	3,500 Added 16.99%	24,100 $469,000
Q4 2021 Feb 14, 2022	BUY	$13.05 - $19.35 $50,895 - $75,465	3,900 Added 23.35%	20,600 $329,000
Q2 2021 Jul 30, 2021	BUY	$15.84 - $20.6 $28,512 - $37,080	1,800 Added 12.08%	16,700 $289,000
Q4 2020 Feb 08, 2021	BUY	$15.75 - $25.45 $23,625 - $38,175	1,500 Added 11.19%	14,900 $260,000
Q2 2020 Aug 13, 2020	BUY	$11.51 - $20.97 $154,234 - $280,998	13,400 New	13,400 $261,000
Q4 2019 Feb 18, 2020	SELL	$6.84 - $25.9 $7.83 Million - $29.7 Million	-1,144,813 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$9.16 - $14.77 $10.5 Million - $16.9 Million	1,144,813 New	1,144,813 $11.5 Million

Others Institutions Holding MIRM

# of Institutions

194

Shares Held

54M

Call Options Held

177K

Put Options Held

167K

View Full List

About Mirum Pharmaceuticals, Inc.

Ticker MIRM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,751,700
Market Cap $1.85B
Description
Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...

More about MIRM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Mirum Pharmaceuticals, Inc. Transaction History